Objective: Early antidepressant response predicts later treatment outcome in patients with major depressive disorder (MDD) [1] . MDD is characterized by changes to the behavioral and neuronal correlates of emotion processing [2] . Functional magnetic resonance imaging (fMRI) studies have demonstrated that neuronal activity related to emotion processing allows for prediction of antidepressant response after 6-8 weeks [3, 4] . We aimed to investigate if emotion processing related fMRI activity predicts early response to antidepressant psychopharmacologic treatment.
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Abstract
We investigated the interactive effects of BclI C/G (rs41423247) allelic variants and the diagnosis of major depressive disorder (MDD) on hippocampal shape and integrity of the left parahippocampal subdivision of the cingulum. Fifty-two patients with MDD and 52 healthy controls (HCs) underwent T1-weighted structural magnetic resonance imaging and BclI C/G (rs41423247) genotyping. We analyzed hippocampal shape using the FIRST module of FSL and analyzed white matter (WM) integrity using diffusion tensor imaging (DTI) and tractbased spatial statistics (TBSS). Significant alterations in left hippocampal shape and decreased fractional anisotropy (FA) values of the left parahippocampal cingulum were observed in MDD patients, compared to HCs. In addition, MDD patients of the BclI minor (G-) allele carrier group showed significant alterations in left hippocampal shape (FDR-corrected, p <.05) and decreased FA values of the left parahippocampal cingulum compared to BclI minor (G-) allele carrier HCs. No significant differences between diagnostic subgroups of the C/C homozygotes were observed. Our study provides evidence for alterations in hippocampal shape and decreased integrity of the WM region associated with the hippocampus in MDD, and for the influence of BclI C/G (rs41423247) on hippocampal shape and integrity of the parahippocampal subdivision of the cingulum in depression.
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